Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.49K Buy
12
+4
+50% +$2.34K ﹤0.01% 2518
2026
Q2
$4.24K Sell
8
-256
-97% -$118K ﹤0.01% 2734
2026
Q1
$127K Sell
264
-175
-40% -$89.6K 0.01% 1030
2025
Q4
$247K Buy
439
+176
+67% +$100K 0.01% 791
2025
Q3
$135K Buy
263
+260
+8,667% +$114K 0.01% 807
2025
Q2
$942 Buy
+3
New +$901 ﹤0.01% 2463
2025
Q1
– Sell
-7
Closed -$2.33K – 2711
2024
Q4
$2.33K Hold
7
– – ﹤0.01% 2249
2024
Q3
$2.34K Buy
+7
New +$2.66K ﹤0.01% 2246

Other funds holding MEDP

BFC Planning's MEDP Position: Q3 2026 in Review

BFC Planning increased its Medpace (MEDP) stake by 50% in Q3 2026, buying an estimated $2.34K and bringing the position to 12 shares worth $7.49K. The position accounts for ﹤0.01% of the portfolio, ranked #2518.

BFC Planning first reported a position in MEDP in Q3 2024 and has held it in 8 quarters since. The position peaked at $247K in Q4 2025. 629 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

  • BFC Planning held 12 shares of Medpace worth $7.49K as of Q3 2026.
  • BFC Planning bought 4 Medpace shares in Q3 2026, an estimated $2.34K.
  • Medpace made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2518 holding.
  • BFC Planning first reported a position in Medpace in Q3 2024 and has held it in 8 quarters since.
  • BFC Planning's Medpace position peaked at $247K in Q4 2025.
  • 629 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.